Full name
PROPHARMA SOLUTIONS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.45.Z - Wholesale trade of perfumes and cosmetics
47.74.Z - Retail sale of medical and orthopedic products
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
73.11.Z - Advertising agency activities
73.12.B - Advertising through mass media
73.12.C - Advertising through mass media
82.20.Z - Call center activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0 | 0,1 | 873,7 |
EBITDA | -0 | -0 | 0,1 | 875,4 |
Short time liabilities | 0 | 0 | 0,5 | 974,1 |
Income tax | ||||
Equity capital | 0,2 | 0,2 | 0,3 | 28 |
Operating profit (EBIT) | -0 | -0 | 0,1 | 875,4 |
Assets | 0,3 | 0,3 | 0,7 | 181 |
Net profit (loss) | -0 | -0 | 0,1 | 756,1 |
Cash | 0 | 0 | 0 | 194,3 |
Net income from sale | 0,3 | 0,2 | 2,1 | 930,3 |
Liabilities and provisions for liabilities | 0 | 0 | 0,5 | 974,1 |
Working assets | 0,3 | 0,3 | 0,7 | 181 |
Basic operational activity income | ||||
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -12,4 | -4,3 | 21,9 | 26,2 |
Equity capital to total assets | 88,8 | 83,8 | 38,2 | -45,6 |
Gross profit margin | -8,9 | -4,6 | 3,4 | 8 |
EBITDA Margin | -8,9 | -4,6 | 3,4 | 8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 33 | 75 | 78 | 3 |
Current financial liquidity indicator | 8.903890609741211 | 6.185495376586914 | 1.6181535720825195 | -4,6 |
Net dept to EBITDA | 0.023392533883452415 | 1.2509994506835938 | -0.4747571349143982 | -1,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane